Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

NCT00548301 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2011-07-01

No results posted yet for this study

Summary

The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

cyclosporine

Sponsors & Collaborators

  • Sirion Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Roger Vogel, MD · Sirion Therapeutics

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00548301 on ClinicalTrials.gov